Panacea Biotec launches anti-diabetes drug vildagliptin day after patent expiry
(WorldNews Health)

Panacea Biotec on Tuesday launched single dose and combination medicines of anti-diabetes drug vildagliptin, the patent for which had expired a day earlier, the company said in a statement. The pharmaceutical company launched the medicine under the brand...